These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23821214)

  • 1. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
    Stenman G
    Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
    Skálová A; Šteiner P; Vaneček T
    Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Pathology of Salivary Gland Neoplasms: Diagnostic, Prognostic, and Predictive Perspective.
    Toper MH; Sarioglu S
    Adv Anat Pathol; 2021 Mar; 28(2):81-93. PubMed ID: 33405400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted RNA sequencing in the routine clinical detection of fusion genes in salivary gland tumors.
    Bubola J; MacMillan CM; Demicco EG; Chami RA; Chung CT; Leong I; Marrano P; Onkal Z; Swanson D; Veremis BM; Weinreb I; Zhang L; Antonescu CR; Dickson BC
    Genes Chromosomes Cancer; 2021 Oct; 60(10):695-708. PubMed ID: 34176176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation-associated salivary gland tumors: a review and update.
    Weinreb I
    Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
    Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
    Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salivary gland cancers: biology and molecular targets for therapy.
    Bell D; Hanna EY
    Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
    Queimado L; Lopes CS; Reis AM
    Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of DNA content in salivary gland tumors].
    Yáñez M; Roa I; Villaseca M; Fuentealba P
    Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers.
    Stenman G; Persson F; Andersson MK
    Oral Oncol; 2014 Aug; 50(8):683-90. PubMed ID: 24856188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ras-P21 in salivary gland tumors.
    Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
    Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
    [No Abstract]   [Full Text] [Related]  

  • 12. [Molecular markers in salivary gland tumors: their use in diagnostic and prognostic workup].
    Fehr A; Stenman G; Bullerdiek J; Löning T
    Pathologe; 2009 Nov; 30(6):466-71. PubMed ID: 19784654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumours of the lacrimal gland. Epidemiological, clinical and genetic characteristics.
    von Holstein SL
    Acta Ophthalmol; 2013 Nov; 91 Thesis 6():1-28. PubMed ID: 24893972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salivary gland cancer: an update on present and emerging therapies.
    Carlson J; Licitra L; Locati L; Raben D; Persson F; Stenman G
    Am Soc Clin Oncol Educ Book; 2013; ():257-63. PubMed ID: 23714518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication of CD166 expression in salivary gland tumor.
    Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
    Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of PLAG1 and HMGA2 by gene fusions involving the transcriptional regulator gene NFIB.
    Afshari MK; Fehr A; Nevado PT; Andersson MK; Stenman G
    Genes Chromosomes Cancer; 2020 Nov; 59(11):652-660. PubMed ID: 32654217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
    Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
    Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of MYB expression and MYB-NFIB gene fusions in adenoid cystic carcinoma and other salivary neoplasms.
    Brill LB; Kanner WA; Fehr A; Andrén Y; Moskaluk CA; Löning T; Stenman G; Frierson HF
    Mod Pathol; 2011 Sep; 24(9):1169-76. PubMed ID: 21572406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
    Bhaijee F; Pepper DJ; Pitman KT; Bell D
    Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
    Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
    Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.